1 – 10 of 100
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progression
- Contribution to journal › Article
-
Mark
Combined targeting of PRDX6 and GSTP1 as a potential differentiation strategy for neuroblastoma treatment
- Contribution to journal › Article
-
Mark
Experimental approaches for modeling and targeting resistant neuroblastoma
(2025) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
- Contribution to journal › Article
-
Mark
Tracing metastatic spread in pediatric solid tumors using copy number and targeted deep sequencing
- Contribution to journal › Article
-
Mark
Evaluation of TRPA1 as a Therapeutic Target in MYCN-Amplified Neuroblastoma
- Contribution to journal › Article
- 2024
-
Mark
Loss of Chromosome Y in Neuroblastoma Is Associated With High-Risk Disease, 11q-Deletion, and Telomere Maintenance
- Contribution to journal › Article
-
Mark
Defining neuroblastoma : From origin to precision medicine
- Contribution to journal › Scientific review
-
Mark
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
- Contribution to journal › Article
- 2023
-
Mark
Patient-derived models : Advanced tools for precision medicine in neuroblastoma
- Contribution to journal › Article
